Sign in

Avidity Biosciences, Inc.

Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-13 Dec-12 Dec-11
Total revenue 0.02 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.01 0.01 0.01
Cost of revenue 0.00 0.00 0.00 0.00 0.00 0.04 0.01 0.01 0.03 0.02 0.03
Gross profit 0.02 0.01 0.01 0.01 0.01 0.01 0.00 -0.01
Total operating expenses + 0.10 0.39 0.24 0.19 0.13 0.05 0.02 0.01
Operating income -0.08 -0.38 -0.24 -0.18 -0.12 -0.04 -0.02 -0.01
Non-operating income (net) 0.00 0.06 0.02 0.00 0.00 0.00 -0.01 0.00 0.00 0.00 0.00
Income before tax -0.08 -0.32 -0.21 -0.17 -0.12 -0.04 -0.02 -0.01
Income tax expense 0.00 0.00 0.00 0.00 0.00 0.01 0.00
Net income -0.08 -0.32 -0.21 -0.17 -0.12 -0.04 -0.02 -0.01
Show Quarterly Income Statement
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Sep-14 Jun-14 Mar-14 Dec-13 Sep-13 Jun-13 Mar-13 Dec-12 Sep-12 Jun-12 Mar-12 Dec-11
Total revenue 0.02 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01
Cost of revenue 0.00 0.00 0.14 0.00 0.00 0.00 0.00 0.00 0.05 0.04 0.05 0.05 0.04 0.04 0.03 0.03 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.01 0.03
Gross profit 0.02 0.00 0.01 -0.13 0.00 0.00 0.00 0.00 0.00 0.00 -0.04 -0.04 -0.05 -0.04 -0.03 -0.04 -0.03 -0.03 -0.02 -0.02 -0.02 -0.01 -0.01 0.00 0.00 0.00 0.00 0.00 0.00
Total operating expenses + 0.04 0.05 0.20 0.04 0.13 0.12 0.10 0.08 0.08 0.07 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.01 0.01 0.01 0.01 0.00 0.00
Operating income -0.02 -0.05 -0.19 -0.17 -0.13 -0.12 -0.10 -0.08 -0.08 -0.07 -0.06 -0.05 -0.06 -0.05 -0.04 -0.05 -0.03 -0.04 -0.03 -0.03 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 0.00 0.00 0.01
Non-operating income (net) 0.00 0.00 0.01 0.01 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Income before tax -0.02 -0.05 -0.17 -0.16 -0.12 -0.10 -0.08 -0.07 -0.07 -0.06 -0.05 -0.05 -0.05 -0.05 -0.04 -0.05 -0.03 -0.04 -0.03 -0.03 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 0.00 0.01
Income tax expense 0.00 0.00 0.00 -0.01 -0.01 -0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net income -0.02 -0.05 -0.17 -0.16 -0.12 -0.10 -0.08 -0.07 -0.07 -0.06 -0.05 -0.05 -0.05 -0.05 -0.04 -0.05 -0.03 -0.04 -0.03 -0.03 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 0.00 0.01
about 2 months ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-13 Dec-12 Dec-11
Total cash and short-term investments + 1.58 1.50 0.60 0.61 0.41 0.33 0.09 0.00 0.11 0.05 0.02
Accounts receivable, net 0.01 0.03 0.01 0.00 0.00 0.00 0.00
Inventories -0.01 0.00 0.00 0.00 0.00
Other current assets 0.00 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total current assets 0.27 1.54 0.61 0.62 0.41 0.33 0.10 0.00
Total non-current assets + 0.01 0.02 0.02 0.02 0.02 0.00 0.00 0.00
Total assets 0.28 1.56 0.63 0.64 0.43 0.33 0.10 0.00 0.13 0.06 0.03
Total current liabilities + 0.04 0.10 0.08 0.05 0.03 0.01 0.01 0.00 0.01 0.02 0.02
Total non-current liabilities + 0.03 0.04 0.05 0.01 0.02 0.01 0.15 0.04
Total liabilities 0.07 0.14 0.13 0.06 0.05 0.03 0.16 0.05 0.04 0.04 0.03
Total stockholders' equity + 0.21 1.42 0.50 0.58 0.38 0.31 -0.07 -0.04 0.09 0.02 0.00
Common shares outstanding 17 112 73 52 41 22 38 21
Show Quarterly Balance Sheet
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Sep-14 Jun-14 Mar-14 Dec-13 Sep-13 Jun-13 Mar-13 Dec-12 Dec-11
Total cash and short-term investments + 0.27 1.58 1.80 1.18 1.38 1.50 1.59 1.30 0.92 0.60 0.54 0.58 0.59 0.61 0.41 0.40 0.40 0.41 0.41 0.28 0.31 0.33 0.34 0.35 0.09 0.09 0.00 0.00 0.00 0.08 0.10 0.11 0.11 0.12 0.04 0.05 0.05 0.02
Accounts receivable, net 0.02 0.01 0.02 0.01 0.04 0.03 0.02 0.02 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventories -0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other current assets 0.00 0.00 0.00 0.06 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.01 0.01 0.01 0.00 0.01 0.00 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total current assets 0.29 0.27 0.27 1.25 1.43 1.54 1.62 1.33 0.93 0.61 0.56 0.59 0.60 0.62 0.41 0.40 0.40 0.41 0.42 0.29 0.31 0.33 0.34 0.35 0.09 0.10 0.00
Total non-current assets + 0.01 0.01 0.01 0.12 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total assets 0.29 0.28 0.28 1.37 1.46 1.56 1.64 1.35 0.95 0.63 0.57 0.61 0.61 0.64 0.43 0.42 0.42 0.43 0.43 0.29 0.31 0.33 0.35 0.36 0.09 0.10 0.09 0.11 0.12 0.13 0.13 0.05 0.06 0.06 0.03
Total current liabilities + 0.02 0.04 0.03 0.14 0.08 0.10 0.09 0.08 0.07 0.08 0.05 0.05 0.05 0.05 0.04 0.03 0.03 0.03 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.02 0.02 0.02 0.02
Total non-current liabilities + 0.04 0.03 0.03 0.04 0.05 0.04 0.05 0.04 0.05 0.05 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.15
Total liabilities 0.06 0.07 0.06 0.18 0.13 0.14 0.14 0.13 0.12 0.13 0.06 0.05 0.06 0.06 0.05 0.05 0.05 0.05 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.16 0.02 0.02 0.02 0.04 0.04 0.04 0.04 0.04 0.03
Total stockholders' equity + 0.23 0.21 0.21 1.19 1.33 1.42 1.50 1.22 0.83 0.50 0.52 0.56 0.56 0.58 0.38 0.37 0.38 0.38 0.39 0.26 0.29 0.31 0.32 0.33 0.07 -0.07 -0.01 0.07 0.09 0.10 0.09 0.09 0.01 0.02 0.02 0.00
Common shares outstanding 17 17 138 130 129 128 123 107 87 76 74 71 70 57 53 50 48 24 43 38 38 37 37 9 31 21 21 21 21 53
about 2 months ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-13 Dec-12 Dec-11
Operating cash flow + -0.04 -0.30 -0.12 -0.14 -0.09 -0.04 0.00 -0.01
Cash flow from investing + 0.00 -0.85 -0.13 -0.19 -0.08 -0.01 0.00 0.00
Cash flow from financing + 0.04 1.19 0.09 0.35 0.18 0.27 0.09 0.01 0.09 0.03 0.00
Change in cash 0.00 0.04 -0.16 0.02 0.00 0.23 0.09 0.00 0.09 0.03 0.00
Show Quarterly Cash Flow
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Sep-14 Jun-14 Mar-14 Dec-13 Sep-13 Jun-13 Mar-13 Dec-12 Dec-11
Operating cash flow + -0.03 -0.02 -0.16 -0.20 -0.12 -0.10 -0.07 -0.07 -0.07 0.02 -0.04 -0.05 -0.05 -0.04 -0.03 -0.04 -0.03 -0.03 -0.02 -0.03 -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 0.02 0.00
Cash flow from investing + 0.00 0.00 -0.59 0.19 0.16 -0.06 -0.48 -0.27 -0.03 0.05 -0.03 0.05 -0.20 -0.01 0.01 -0.02 -0.18 -0.08 0.00 0.00 0.00 -0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash flow from financing + 0.30 0.02 0.85 0.00 0.00 0.01 0.34 0.45 0.39 0.03 0.00 0.04 0.02 0.24 0.04 0.04 0.02 0.02 0.16 0.00 0.00 0.00 0.00 0.27 0.00 0.07 0.00 0.01 0.00 0.00 0.00 0.09 0.09 0.00 0.03 0.00
Change in cash 0.27 0.00 0.11 -0.01 0.03 -0.15 -0.21 0.11 0.29 0.10 -0.07 0.04 -0.22 0.20 0.02 -0.01 -0.18 -0.09 0.13 -0.02 -0.02 -0.02 -0.01 0.26 -0.01 0.07 -0.01 0.03 0.00 0.00 0.00 0.00 0.09 0.09 0.00 0.00 0.03 0.00
about 2 months ago

Avidity Biosciences, Inc. (RNA) - Ebitda

1Y 2Y 5Y Max
about 2 months ago

Avidity Biosciences, Inc. (RNA) - Ebit

1Y 2Y 5Y Max
about 2 months ago

Avidity Biosciences, Inc. (RNA) - Net Income From Continuing Operations

1Y 2Y 5Y Max
about 2 months ago

Avidity Biosciences, Inc. (RNA) - Income Tax Expense

1Y 2Y 5Y Max
about 2 months ago

Avidity Biosciences, Inc. (RNA) - Income Before Tax

1Y 2Y 5Y Max
about 2 months ago

Avidity Biosciences, Inc. (RNA) - Depreciation And Amortization

1Y 2Y 5Y Max
about 2 months ago

Avidity Biosciences, Inc. (RNA) - Operating Expenses

1Y 2Y 5Y Max
about 2 months ago

Avidity Biosciences, Inc. (RNA) - Research And Development

1Y 2Y 5Y Max
about 2 months ago

Avidity Biosciences, Inc. (RNA) - Selling General And Administrative

1Y 2Y 5Y Max
about 2 months ago

Avidity Biosciences, Inc. (RNA) - Operating Income

1Y 2Y 5Y Max
about 2 months ago